1-76412215-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152996.4(ST6GALNAC3):āc.421G>Cā(p.Asp141His) variant causes a missense change. The variant allele was found at a frequency of 0.0000526 in 152,016 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_152996.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ST6GALNAC3 | NM_152996.4 | c.421G>C | p.Asp141His | missense_variant | 3/5 | ENST00000328299.4 | NP_694541.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ST6GALNAC3 | ENST00000328299.4 | c.421G>C | p.Asp141His | missense_variant | 3/5 | 1 | NM_152996.4 | ENSP00000329214.3 | ||
ST6GALNAC3 | ENST00000464140.1 | n.295G>C | non_coding_transcript_exon_variant | 2/3 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152016Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251050Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135662
GnomAD4 exome Cov.: 31
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152016Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74244
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 21, 2024 | The c.421G>C (p.D141H) alteration is located in exon 3 (coding exon 3) of the ST6GALNAC3 gene. This alteration results from a G to C substitution at nucleotide position 421, causing the aspartic acid (D) at amino acid position 141 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at